Design, synthesis and structure–activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: Dual activity as cholinesterase and Aβ-aggregation inhibitors
- 1 April 2011
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (7) , 2269-2281
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Protein aggregation diseases: pathogenicity and therapeutic perspectivesNature Reviews Drug Discovery, 2010
- hChAT: A Tool for the Chemoenzymatic Generation of Potential Acetyl/Butyrylcholinesterase InhibitorsChemBioChem, 2009
- Application of Fragment-Based Lead Generation to the Discovery of Novel, Cyclic Amidine β-Secretase Inhibitors with Nanomolar Potency, Cellular Activity, and High Ligand EfficiencyJournal of Medicinal Chemistry, 2007
- Therapies for Alzheimer's diseaseNature Reviews Drug Discovery, 2007
- Therapeutic approaches to Alzheimer's diseaseBrain, 2006
- Editorial [Hot Topic: Type II Diabetes (Executive Editor: Ulf Smith)]Current Molecular Medicine, 2005
- Neurobiology of butyrylcholinesteraseNature Reviews Neuroscience, 2003
- Alzheimer's Disease Is a Synaptic FailureScience, 2002
- Use of cholinesterase inhibitors in dementiaAdvances in Psychiatric Treatment, 2002
- Molecular Dynamics of AcetylcholinesteraseAccounts of Chemical Research, 2002